95.23 - 97.14
55.47 - 103.81
1.63M / 1.80M (Avg.)
55.57 | 1.74
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
21.32%
EBIT growth 50-75% of FSM's 41.81%. Martin Whitman would suspect suboptimal resource allocation.
21.32%
Operating income growth at 50-75% of FSM's 41.81%. Martin Whitman would doubt the firm’s ability to compete efficiently.
-498.04%
Negative net income growth while FSM stands at 35.05%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-498.20%
Negative EPS growth while FSM is at 35.14%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-498.20%
Negative diluted EPS growth while FSM is at 35.14%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
1345.03%
Positive OCF growth while FSM is negative. John Neff would see this as a clear operational advantage vs. the competitor.
1345.03%
Positive FCF growth while FSM is negative. John Neff would see a strong competitive edge in net cash generation.
-100.00%
Negative 10Y revenue/share CAGR while FSM stands at 0.00%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-100.00%
Negative 5Y CAGR while FSM stands at 0.00%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-100.00%
Negative 3Y CAGR while FSM stands at 0.00%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
3333.85%
3Y OCF/share CAGR of 3333.85% while FSM is zero. Bruce Berkowitz might see if small gains can expand into a broader advantage.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-1740.38%
Negative 3Y CAGR while FSM is 0.00%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
8252.36%
Equity/share CAGR of 8252.36% while FSM is zero. Bruce Berkowitz might see a slight advantage that can compound significantly over 10 years.
8252.36%
Equity/share CAGR of 8252.36% while FSM is zero. Bruce Berkowitz might see a minor advantage that could compound if the firm maintains positive net worth growth.
8577.55%
Equity/share CAGR of 8577.55% while FSM is zero. Bruce Berkowitz sees if minor gains can snowball into a bigger lead soon.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
3578.51%
Our AR growth while FSM is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.
No Data
No Data available this quarter, please select a different quarter.
17000.92%
Asset growth above 1.5x FSM's 459.14%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
16152.91%
BV/share growth above 1.5x FSM's 170.66%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-21.32%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.